PharmaShots | Incisive News in 3 Shots

Subscribe Now

Velsipity

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2024

March 20, 2024

Pfizer’s Velsipity (etrasimod) Receives the European Commission’s Approval for the Treatment of Severely Active Ulcerative Colitis

Pfizer’s Velsipity (etrasimod) Receives the European Commission’s Approval for the Treatment of Severely Active Ulcerative Colitis

February 20, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us